2025-14460NoticeWallet

FDA Offers Fee Breaks to Struggling Small Device Makers

Published Date: 7/31/2025

Notice

Summary

Hey small medical device businesses! The FDA just updated the rules on how you can prove financial hardship to skip some registration fees. This new guidance explains what info you need to share and how the FDA will decide if you qualify—making it easier to save money and keep innovating.

Analyzed Economic Effects

2 provisions identified: 1 benefits, 0 costs, 1 mixed.

Waiver for Registration Fee If Hardship

If you run a small medical device business, the FDA’s final guidance explains how the Agency will determine whether your firm is experiencing “financial hardship” that makes it eligible for a waiver of its registration fee. This guidance updates the prior guidance issued August 1, 2018 and says FDA will use the updated criteria to decide waiver eligibility.

Guidance Lists Information FDA Will Review

The guidance details what information the FDA intends to review and consider when deciding whether a small medical device business qualifies for a financial-hardship waiver. If you apply for the waiver, you will need to provide the information the guidance lists so FDA can make its determination.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
7/31/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in